🚀 VC round data is live in beta, check it out!
Eurowag Valuation Multiples
Discover revenue and EBITDA valuation multiples for Eurowag and similar public comparables like Clover Health, Hapvida, GoodRx, Ibotta and more.
Eurowag Overview
About Eurowag
WAG Payment Solutions PLC, formerly Eurowag is a pan-European integrated payment & mobility platform focused on the commercial road transport industry. The group's business involves the provision of services to the CRT industry which is focused on two primary segments: Payment solutions, comprising energy payments through pre-pay or post-pay fuel cards and toll payments; and Mobility solutions, comprising tax refund services; telematics; smart routing apps; and other adjacent services.
Founded
2021
HQ
Employees
1.9K
Website
Financials (LTM)
EV
$1B
Eurowag Financials
Eurowag reported last 12-month revenue of $391M and EBITDA of $157M.
In the same LTM period, Eurowag generated $157M in EBITDA and $10M in net income.
Revenue (LTM)
Eurowag P&L
In the most recent fiscal year, Eurowag reported revenue of $3B and EBITDA of $117M.
Eurowag expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $391M | XXX | $3B | XXX | XXX | XXX |
| Gross Profit | — | XXX | $337M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 13% | XXX | XXX | XXX |
| EBITDA | $157M | XXX | $117M | XXX | XXX | XXX |
| EBITDA Margin | 40% | XXX | 5% | XXX | XXX | XXX |
| EBIT Margin | 23% | XXX | 3% | XXX | XXX | XXX |
| Net Profit | $10M | XXX | $3M | XXX | XXX | XXX |
| Net Margin | 3% | XXX | 0% | XXX | XXX | XXX |
| Net Debt | — | — | $441M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Eurowag Stock Performance
Eurowag has current market cap of $1B, and enterprise value of $1B.
Market Cap Evolution
Eurowag's stock price is $1.49.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1B | $1B | — | XXX | XXX | XXX | $0.00 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialEurowag Valuation Multiples
Eurowag trades at 3.4x EV/Revenue multiple, and 8.6x EV/EBITDA.
EV / Revenue (LTM)
Eurowag Financial Valuation Multiples
As of March 28, 2026, Eurowag has market cap of $1B and EV of $1B.
Equity research analysts estimate Eurowag's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Eurowag has a P/E ratio of 107.3x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1B | XXX | $1B | XXX | XXX | XXX |
| EV (current) | $1B | XXX | $1B | XXX | XXX | XXX |
| EV/Revenue | 3.4x | XXX | 0.5x | XXX | XXX | XXX |
| EV/EBITDA | 8.6x | XXX | 11.5x | XXX | XXX | XXX |
| EV/EBIT | 14.8x | XXX | 17.2x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 4.0x | XXX | XXX | XXX |
| P/E | 107.3x | XXX | 332.6x | XXX | XXX | XXX |
| EV/FCF | 15.4x | XXX | 14.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Eurowag Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Eurowag Margins & Growth Rates
Eurowag's revenue in the last 12 month grew by 10%.
Eurowag's revenue per employee in the last FY averaged $0.2M.
Eurowag's rule of 40 is 50% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Eurowag's rule of X is 64% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Eurowag Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 10% | XXX | (85%) | XXX | XXX | XXX |
| EBITDA Margin | 40% | XXX | 5% | XXX | XXX | XXX |
| EBITDA Growth | 11% | XXX | 31% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 50% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 64% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 10% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Eurowag Public Comps
See public comps and valuation multiples for other B2B Payments and Health Benefits & Financial Solutions comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Clover Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Hapvida | XXX | XXX | XXX | XXX | XXX | XXX |
| GoodRx | XXX | XXX | XXX | XXX | XXX | XXX |
| Ibotta | XXX | XXX | XXX | XXX | XXX | XXX |
| QuinStreet | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Eurowag M&A Activity
Eurowag acquired XXX companies to date.
Last acquisition by Eurowag was on XXXXXXXX, XXXXX. Eurowag acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Eurowag
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialEurowag Investment Activity
Eurowag invested in XXX companies to date.
Eurowag made its latest investment on XXXXXXXX, XXXXX. Eurowag invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Eurowag
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Eurowag
| When was Eurowag founded? | Eurowag was founded in 2021. |
| Where is Eurowag headquartered? | Eurowag is headquartered in United Kingdom. |
| How many employees does Eurowag have? | As of today, Eurowag has over 1K employees. |
| Is Eurowag publicly listed? | Yes, Eurowag is a public company listed on London Stock Exchange. |
| What is the stock symbol of Eurowag? | Eurowag trades under EWG ticker. |
| When did Eurowag go public? | Eurowag went public in 2021. |
| Who are competitors of Eurowag? | Eurowag main competitors are Clover Health, Hapvida, GoodRx, Ibotta. |
| What is the current market cap of Eurowag? | Eurowag's current market cap is $1B. |
| What is the current revenue of Eurowag? | Eurowag's last 12 months revenue is $391M. |
| What is the current revenue growth of Eurowag? | Eurowag revenue growth (NTM/LTM) is 10%. |
| What is the current EV/Revenue multiple of Eurowag? | Current revenue multiple of Eurowag is 3.4x. |
| Is Eurowag profitable? | Yes, Eurowag is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Eurowag? | Eurowag's last 12 months EBITDA is $157M. |
| What is Eurowag's EBITDA margin? | Eurowag's last 12 months EBITDA margin is 40%. |
| What is the current EV/EBITDA multiple of Eurowag? | Current EBITDA multiple of Eurowag is 8.6x. |
| What is the current FCF of Eurowag? | Eurowag's last 12 months FCF is $87M. |
| What is Eurowag's FCF margin? | Eurowag's last 12 months FCF margin is 22%. |
| What is the current EV/FCF multiple of Eurowag? | Current FCF multiple of Eurowag is 15.4x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.